X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (164) 164
index medicus (146) 146
hematology (123) 123
aged (92) 92
oncology (92) 92
male (90) 90
female (89) 89
middle aged (88) 88
multiple myeloma (75) 75
bortezomib (68) 68
adult (64) 64
aged, 80 and over (64) 64
treatment outcome (51) 51
multiple myeloma - drug therapy (50) 50
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
prognosis (44) 44
survival (41) 41
dexamethasone (36) 36
cancer (35) 35
multiple-myeloma (35) 35
stem-cell transplantation (35) 35
hematology, oncology and palliative medicine (30) 30
lenalidomide (29) 29
thalidomide (29) 29
chemotherapy (26) 26
antineoplastic agents - therapeutic use (25) 25
therapy (23) 23
multiple myeloma - complications (22) 22
survival analysis (21) 21
thalidomide - analogs & derivatives (21) 21
abridged index medicus (20) 20
care and treatment (20) 20
multiple myeloma - mortality (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
multiple myeloma - diagnosis (18) 18
rituximab (18) 18
waldenstrom macroglobulinemia - drug therapy (18) 18
consensus panel recommendations (17) 17
multiple myeloma - pathology (17) 17
survival rate (16) 16
combination (15) 15
dexamethasone - administration & dosage (15) 15
monoclonal gammopathy (15) 15
amyloidosis (14) 14
analysis (14) 14
dexamethasone - therapeutic use (14) 14
disease-free survival (14) 14
neoplasm staging (14) 14
patient outcomes (14) 14
retrospective studies (14) 14
2nd international workshop (13) 13
boronic acids - therapeutic use (13) 13
diagnosis (13) 13
expression (13) 13
medical research (13) 13
multivariate analysis (13) 13
pharmacology & pharmacy (13) 13
pyrazines - therapeutic use (13) 13
thalidomide - administration & dosage (13) 13
waldenstrom macroglobulinemia - pathology (13) 13
al amyloidosis (12) 12
biomarkers (12) 12
follow-up studies (12) 12
medical prognosis (12) 12
myeloma (12) 12
risk factors (12) 12
thalidomide - therapeutic use (12) 12
angiogenesis (11) 11
antineoplastic agents - adverse effects (11) 11
boronic acids - administration & dosage (11) 11
carfilzomib (11) 11
disease (11) 11
disease progression (11) 11
drug therapy (11) 11
light-chain amyloidosis (11) 11
medical colleges (11) 11
melphalan (11) 11
multiple myeloma - therapy (11) 11
patients (11) 11
plus dexamethasone (11) 11
pyrazines - administration & dosage (11) 11
refractory multiple-myeloma (11) 11
thalidomide - adverse effects (11) 11
biopsy (10) 10
ibrutinib (10) 10
kaplan-meier estimate (10) 10
multiple myeloma - blood (10) 10
phase-ii (10) 10
recurrence (10) 10
waldenstrom macroglobulinemia - diagnosis (10) 10
waldenstrom macroglobulinemia - therapy (10) 10
zoledronic acid (10) 10
antibodies, monoclonal - therapeutic use (9) 9
article (9) 9
cyclophosphamide - administration & dosage (9) 9
immunoglobulin light chains - blood (9) 9
immunoglobulin light-chain amyloidosis (9) 9
immunoglobulins (9) 9
immunologic factors - therapeutic use (9) 9
low-dose dexamethasone (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Medicine, ISSN 0025-7974, 11/2019, Volume 98, Issue 44, p. e17794
Byline: Maria Gavriatopoulou, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e121 - e122
Journal Article
Haematologica, ISSN 0390-6078, 01/2015, Volume 100, Issue 10, pp. 1254 - 1266
Journal Article
American Journal of Hematology, ISSN 0361-8609, 04/2015, Volume 90, Issue 4, pp. E60 - E65
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4188 - 4188
Abstract The malignant plasma cell of Multiple Myeloma (MM) is closely linked to dysregulated unfolded protein response in the ER due to increased production... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 19, pp. 3276 - 3282
Journal Article
Journal of Blood Medicine, ISSN 1179-2736, 08/2019, Volume 10, pp. 291 - 300
Waldenstrom’s macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma with indolent course and prolonged disease course. The first-in-class Bruton’s... 
Cardiac arrhythmia | Cytokines | Leukemia | Bone marrow | Lymphomas | FDA approval | Mutation
Journal Article